{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:33:11Z","timestamp":1793424791184,"version":"4.5.0"},"reference-count":234,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>\n                    Atopic dermatitis (AD) is a common, chronic and relapsing inflammatory skin disease with various clinical presentations and combinations of symptoms. The pathophysiology of AD is complex and multifactorial. There are several factors involved in the etiopathogenesis of AD including structural and immunological epidermal barrier defect, imbalance of the skin microbiome, genetic background and environmental factors. Alterations in structural proteins, lipids, proteases, and their inhibitors, lead to the impairment of the stratum corneum which is associated with the increased skin penetration and transepidermal water loss. The elevated serum immunoglobulin E levels and blood eosinophilia have been shown in the majority of AD patients. Type 2 T-helper cell immune pathway with increased expression of interleukin (IL)-4, IL-5, and IL-13, has an important role in the etiopathogenesis of AD. Both T cells and keratinocytes contribute to epidermal barrier impairment in AD via a dynamic interaction of cytokines and chemokines. The skin microbiome is another factor of relevance in the etiopathogenesis of AD. It has been shown that during AD flares,\n                    <jats:italic>Staphylococcus aureus<\/jats:italic>\n                    (\n                    <jats:italic>S. aureus<\/jats:italic>\n                    ) colonization increased, while\n                    <jats:italic>Staphylococcus epidermidis<\/jats:italic>\n                    (\n                    <jats:italic>S. epidermidis<\/jats:italic>\n                    ) decreased. On the contrary,\n                    <jats:italic>S. epidermidis<\/jats:italic>\n                    and species of\n                    <jats:italic>Streptococcus<\/jats:italic>\n                    , Corynebacterium and Propionibacterium increased during the remision phases. However, it is not clear whether skin dysbiosis is one of the symptoms or one of the causes of AD. There are several therapeutic options, targeting these pathways which play a critical role in the etiopathogenesis of AD. Although topical steroids are the mainstay of the treatment of AD, new biological therapies including IL-4, IL-13, and IL-31 inhibitors, as well as Janus kinase inhibitors (JAKi), increasingly gain more importance with new advances in the therapy of AD. In this review, we summarize the role of immunological and structural epidermal barrier dysfunction, immune abnormalities, impairment of lipids, filaggrin mutation and skin microbiome in the etiopathogenesis of AD, as well as the therapeutic options for AD and their effects on these abnormalities in AD skin.\n                  <\/jats:p>","DOI":"10.3389\/fmolb.2023.1159404","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T09:08:44Z","timestamp":1692263324000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":90,"title":["The immunological and structural epidermal barrier dysfunction and skin microbiome in atopic dermatitis-an update"],"prefix":"10.3389","volume":"10","author":[{"given":"Tubanur","family":"\u00c7etinarslan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"K\u00fcmper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"F\u00f6lster-Holst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"752","DOI":"10.5114\/ada.2019.91425","article-title":"Efficacy and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis: meta-analysis of randomized clinical trials","volume":"36","author":"Abedz\u00b4","year":"2019","journal-title":"Postepy. Dermatol. Alergol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.coi.2020.02.007","article-title":"Recent advances in atopic dermatitis","volume":"66","author":"Ahn","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.jaci.2014.09.023","article-title":"The role of air pollutants in atopic dermatitis","volume":"134","author":"Ahn","year":"2014","journal-title":"J. Allergy. Clin. Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/j.1398-9995.2006.01153.x","article-title":"Diagnosis and treatment of atopic dermatitis in children and adults: european academy of allergology and clinical immunology\/American academy of allergy, asthma and immunology\/PRACTALL consensus report","volume":"61","author":"Akdis","year":"2006","journal-title":"Allergy"},{"key":"B5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/bjd.17869","article-title":"Conjunctivitis in dupilumab clinical trials","volume":"181","author":"Akinlade","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1159\/000362789","article-title":"The human cathelicidin LL-37 host defense peptide upregulates tight junction-related proteins and increases human epidermal keratinocyte barrier function","volume":"6","author":"Akiyama","year":"2014","journal-title":"Innate. Immun."},{"key":"B7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1396-0296.2004.04s1002.x","article-title":"Cleansing without compromise: the impact of cleansers on the skin barrier and the technology of mild cleansing","volume":"17","author":"Ananthapadmanabhan","year":"2004","journal-title":"Dermatol. Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.jaci.2018.08.042","article-title":"Injury, dysbiosis, and filaggrin deficiency drive skin inflammation through keratinocyte IL-1\u03b1 release","volume":"143","author":"Archer","year":"2019","journal-title":"J. Allergy. Clin. Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1136\/bmj.38376.439653.D3","article-title":"Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials","volume":"330","author":"Ashcroft","year":"2005","journal-title":"BMJ"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2005.02980.x","article-title":"The role of microorganisms in atopic dermatitis","volume":"144","author":"Baker","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jconrel.2016.08.007","article-title":"The role of tight junctions in skin barrier function and dermal absorption","volume":"242","author":"Basler","year":"2016","journal-title":"J. Control. Release."},{"key":"B12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1365-2133.2010.09743.x","article-title":"Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an updated cochrane review","volume":"163","author":"Bath-Hextall","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"029455","DOI":"10.1128\/mBio.02945-19","article-title":"Universal dermal microbiome in human skin","volume":"11","author":"Bay","year":"2020","journal-title":"mBio"},{"key":"B14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","article-title":"Role of the microbiota in immunity and inflammation","volume":"157","author":"Belkaid","year":"2014","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1111\/all.15432","article-title":"Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis","volume":"77","author":"Berdyshev","year":"2022","journal-title":"Allergy"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e98006","DOI":"10.1172\/jci.insight.98006","article-title":"Lipid abnormalities in atopic skin are driven by type 2 cytokines","volume":"22","author":"Berdyshev","year":"2018","journal-title":"JCI. Insight."},{"key":"B17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41573-021-00266-6","article-title":"Atopic dermatitis: an expanding therapeutic pipeline for a complex disease","volume":"21","author":"Bieber","year":"2022","journal-title":"Nat. Rev. Drug. Discov."},{"key":"B18","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/bjd.14871","article-title":"Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial","volume":"175","author":"Bissonnette","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1111\/bjd.15390","article-title":"The role of the skin microbiome in atopic dermatitis: a systematic review","volume":"177","author":"Bjerre","year":"2017","journal-title":"Br. J. Dermatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1067\/mjd.2001.117525","article-title":"Macrolactam immunomodulators for topical treatment of inflammatory skin diseases","volume":"45","author":"Bornhovd","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.clindermatol.2017.03.004","article-title":"Current concepts in the prevention of atopic dermatitis","volume":"36","author":"Boulos","year":"2018","journal-title":"Clin. Dermatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1084\/jem.20082242","article-title":"Kallikrein 5 induces atopic dermatitis\u2013like lesions through PAR2- mediated thymic stromal lymphopoietin expression in Netherton syndrome","volume":"206","author":"Briot","year":"2009","journal-title":"J. Exp. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jaad.2016.02.1228","article-title":"Systematic review and meta-analysis of randomized clinical trials (RCTs) comparing topical calcineurin inhibitors with topical corticosteroids for atopic dermatitis: a 15-year experience","volume":"75","author":"Broeders","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/jid.2011.393","article-title":"One remarkable molecule: filaggrin","volume":"132","author":"Brown","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/s0022-3476(98)70498-6","article-title":"Atopic dermatitis and food hypersensitivity reactions","volume":"132","author":"Burks","year":"1998","journal-title":"J. Pediatr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"adv00160","DOI":"10.2340\/00015555-3510","article-title":"Prevalence and incidence of atopic dermatitis: a systematic review","volume":"100","author":"Bylund","year":"2020","journal-title":"Acta. Derm. Venereol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"eaal4651","DOI":"10.1126\/scitranslmed.aal4651","article-title":"Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis","volume":"9","author":"Byrd","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/DER.0b013e318290c57f","article-title":"Winter season, frequent hand washing, and irritant patch test reactions to detergents are associated with hand dermatitis in health care workers","volume":"24","author":"Callahan","year":"2013","journal-title":"Dermatitis"},{"key":"B29","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jid.2019.05.024","article-title":"IL-4R\u03b1 blockade by dupilumab decreases Staphylococcus aureus colonization and increases microbial diversity in atopic dermatitis","volume":"140","author":"Callewaert","year":"2020","journal-title":"J. Invest. Dermatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jaip.2019.10.007","article-title":"The association between season of birth and atopic dermatitis in the northern hemisphere: a systematic review and metaanalysis","volume":"8","author":"Calov","year":"2020","journal-title":"J. Allergy. Clin. Immunol. Pract."},{"key":"B31","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1164\/rccm.200610-1563O","article-title":"Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease","volume":"176","author":"Calverley","year":"2007","journal-title":"Am. J. Respir. Crit. Care. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1182\/bloodadvances.2016002352","article-title":"IL-33, IL-25, and TSLP induce a distinct phenotypic and activation profile in human type 2 innate lymphoid cells","volume":"1","author":"Camelo","year":"2017","journal-title":"Blood. Adv."},{"key":"B33","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1067\/mjd.2002.124617","article-title":"Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity","volume":"47","author":"Chamlin","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1067\/mai.2001.117455","article-title":"Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin","volume":"108","author":"Cho","year":"2001","journal-title":"J. Allergy. Clin. Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.3390\/cancers15123219","article-title":"Allergic diseases and risk of malignancy of gastrointestinal cancers","volume":"15","author":"Choi","year":"2023","journal-title":"Cancers. (Basel)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11882-022-01033-2","article-title":"Aeroallergens in atopic dermatitis and chronic urticaria","volume":"22","author":"Chong","year":"2022","journal-title":"Curr. Allergy. Asthma. Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1001\/jamadermatol.2017.5440","article-title":"Association of disease severity with skin microbiome and filaggrin gene mutations in adult atopic dermatitis","volume":"154","author":"Clausen","year":"2018","journal-title":"JAMA. Dermatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1111\/bjd.15470","article-title":"Staphylococcus aureus colonization in atopic eczema and its association with filaggrin gene mutations","volume":"177","author":"Clausen","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1038\/jid.2009.133","article-title":"Epidermal barrier dysfunction in atopic dermatitis","volume":"129","author":"Cork","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jaci.2006.04.042","article-title":"New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions","volume":"118","author":"Cork","year":"2006","journal-title":"J. Allergy. Clin. Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaci.2018.10.032","article-title":"Atopic dermatitis endotypes and implications for targeted therapeutics","volume":"143","author":"Czarnowicki","year":"2019","journal-title":"J. Allergy. Clin. Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.jaci.2015.08.013","article-title":"Petrolatum: barrier repair and antimicrobial responses underlying this \u2018\u2018inert\u2019\u2019 moisturizer","volume":"137","author":"Czarnowicki","year":"2016","journal-title":"J. Allergy. Clin. Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jdermsci.2015.11.013","article-title":"Expression of dermcidin in sebocytes supports a role for sebum in the constitutive innate defense of human skin","volume":"81","author":"Dahlhoff","year":"2016","journal-title":"J. Dermatol. Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jid.2017.08.037","article-title":"The effect of water hardness on surfactant deposition after washing and subsequent skin irritation in atopic dermatitis patients and healthy control subjects","volume":"138","author":"Danby","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jdermsci.2017.05.005","article-title":"Altered expression of epidermal lipid bio-synthesis enzymes in atopic dermatitis skin is accompanied by changes in stratum corneum lipid composition","volume":"88","author":"Danso","year":"2017","journal-title":"J. Dermatol. Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1203\/pdr.0b013e3180459f75","article-title":"Effect of topical emollient treatment of preterm neonates in Bangladesh on invasion of pathogens into the bloodstream","volume":"61","author":"Darmstadt","year":"2007","journal-title":"Pediatr. Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3390\/microorganisms9020353","article-title":"Gut-skin Axis: current knowledge of the interrelationship between microbial dysbiosis and skin conditions","volume":"9","author":"De Pessemier","year":"2021","journal-title":"Microorganisms"},{"key":"B48","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1016\/j.jaad.2005.04.030","article-title":"Corticosteroids: options in the era of steroid-sparing therapy","volume":"53","author":"Del Rosso","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1046\/j.1523-1747.1998.00364.x","article-title":"Low humidity stimulates epidermal DNA synthesis and amplifies the hyperproliferative response to barrier disruption: implication for seasonal exacerbations of inflammatory dermatoses","volume":"111","author":"Denda","year":"1998","journal-title":"J. Invest. Dermatol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1080\/1744666X.2019.1564038","article-title":"Topical agents for the treatment of atopic dermatitis","volume":"15","author":"Diaz","year":"2019","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1111\/bjd.16340","article-title":"Systematic review of atopic dermatitis disease definition in studies using routinely collected health data","volume":"178","author":"Dizon","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.anai.2019.10.008","article-title":"The role of filaggrin in atopic dermatitis and allergic disease","volume":"124","author":"Drislane","year":"2020","journal-title":"Ann. Allergy. Asthma. Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1034\/j.1399-3038.2000.00071.x","article-title":"Diagnosis of IgE-mediated food allergy among Swiss children with atopic dermatitis","volume":"11","author":"Eigenmann","year":"2000","journal-title":"Pediatr. Allergy. Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.jaci.2017.01.039","article-title":"Proteomic analysis of filaggrin deficiency identifies molecular signatures characteristic of atopic eczema","volume":"140","author":"Elias","year":"2017","journal-title":"J. Allergy. Clin. Immunol."},{"key":"B55","first-page":"63","article-title":"Physiologic lipids for barrier repair in dermatology","volume-title":"Cosmeceuticals","author":"Elias","year":"2005"},{"key":"B56","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.0022-202X.2005.23668.x","article-title":"Stratum corneum defensive functions: an integrated view","volume":"125","author":"Elias","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000493641","article-title":"Moisturizers versus current and nextgeneration barrier repair therapy for the management of atopic dermatitis","volume":"32","author":"Elias","year":"2019","journal-title":"Skin. Pharmacol. Physiol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/01206501-199909000-00001","article-title":"Epidermal pathogenesis of inflammatory dermatoses","volume":"10","author":"Elias","year":"1999","journal-title":"Am. J. Contact. Dermatol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/ng.347","article-title":"A common variant on chromosome 11q13 is associated with atopic dermatitis","volume":"41","author":"Esparza-Gordillo","year":"2009","journal-title":"Nat. Genet."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1007\/s00394-019-02061-x","article-title":"Probiotics modulate the gut microbiota composition and immune responses in patients with atopic dermatitis: a pilot study","volume":"59","author":"Fang","year":"2020","journal-title":"Eur. J. Nutr."},{"key":"B61","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jaci.2016.02.020","article-title":"The pruritus- and TH2-associated cytokine IL-31 promotes growth of sensory nerves","volume":"138","author":"Feld","year":"2016","journal-title":"J. Allergy. Clin. Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.clindermatol.2018.05.004","article-title":"Skin diseases associated with atopic dermatitis","volume":"36","author":"Fenner","year":"2018","journal-title":"Clin. Dermatol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/ddg.14709","article-title":"The role of the skin microbiome in atopic dermatitis-correlations and consequences","volume":"20","author":"F\u00f6lster-Holst","year":"2022","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"B64","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s40265-022-01722-2","article-title":"New topical therapies in development for atopic dermatitis","volume":"82","author":"Freitas","year":"2022","journal-title":"Drugs"},{"key":"B65","doi-asserted-by":"publisher","first-page":"15258","DOI":"10.1074\/jbc.272.24.15258","article-title":"The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders","volume":"272","author":"Frohm","year":"1997","journal-title":"J. Biol. Chem."},{"key":"B66","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/all.13239","article-title":"Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis","volume":"73","author":"Furue","year":"2018","journal-title":"Allergy"},{"key":"B67","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jid.2018.08.028","article-title":"Atopic dermatitis in America study: a cross-sectional study examining the prevalence and disease burden of atopic dermatitis in the US adult population","volume":"139","author":"Fuxench","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1126\/science.aad9378","article-title":"How colonization by microbiota in early life shapes the immune system","volume":"352","author":"Gensollen","year":"2016","journal-title":"Science"},{"key":"B69","doi-asserted-by":"publisher","first-page":"120","DOI":"10.5415\/apallergy.2016.6.2.120","article-title":"A review on the role of moisturizers for atopic dermatitis","volume":"6","author":"Giam","year":"2016","journal-title":"Asia. Pac. Allergy."},{"key":"B70","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1371\/journal.pone.0192443","article-title":"Emollient therapy alters skin barrier and microbes in infants at risk for developing atopic dermatitis","volume":"135","author":"Glatz","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"B71","first-page":"507","article-title":"Beyond inflammation: tolerance, immunotherapy and more","volume":"9","author":"Goerdt","year":"1999","journal-title":"Eur. J. Dermatol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/j.1365-2133.1991.tb14807.x","article-title":"\u2018Wet-wrap\u2019 dressings for the treatment of atopic eczema in children","volume":"125","author":"Goodyear","year":"1991","journal-title":"Br. J. Dermatol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1001\/jamadermatol.2019.2983","article-title":"Use of tape strips to detect immune and barrier abnormalities in the skin of children with early-onset atopic dermatitis","volume":"155","author":"Guttman-Yassky","year":"2019","journal-title":"JAMA, Dermatol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.jaci.2009.09.031","article-title":"Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis","volume":"124","author":"Guttman-Yassky","year":"2009","journal-title":"J. Allergy. Clin. Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1016\/j.jid.2016.06.627","article-title":"Aryl hydrocarbon receptor in keratinocytes is essential for murine skin barrier integrity","volume":"136","author":"Haas","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"97","DOI":"10.12688\/wellcomeopenres.15729.2","article-title":"Changes in nano-mechanical properties of human epidermal cornified cells in children with atopic dermatitis","volume":"17","author":"Haftek","year":"2020","journal-title":"Wellcome. Open. Res."},{"key":"B77","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/ics.12049","article-title":"Filaggrin - revisited","volume":"35","author":"Harding","year":"2013","journal-title":"Int. J. Cosmet. Sci."},{"key":"B78","doi-asserted-by":"publisher","first-page":"eaan5918","DOI":"10.1126\/sciimmunol.aan5918","article-title":"CD1a presentation of endogenous antigens by group 2 innate lymphoid cells","volume":"22","author":"Hardman","year":"2017","journal-title":"Sci. Immunol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/j.0022-202X.2005.23651.x","article-title":"Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis factor-alpha and interferon-gamma in human epidermis","volume":"124","author":"Hatano","year":"2005","journal-title":"J. Investig. Dermatol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/ACI.0000000000000652","article-title":"The show must go on: an update on clinical experiences and clinical studies on novel pharmaceutical developments for the treatment of atopic dermatitis","volume":"20","author":"Honstein","year":"2020","journal-title":"Curr. Opin. Allergy. Clin. Immunol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jaci.2007.04.031","article-title":"Cytokine modulation of atopic dermatitis filaggrin skin expression","volume":"120","author":"Howell","year":"2007","journal-title":"J. Allergy. Clin. Immunol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jaci.2018.09.031","article-title":"Nonatopic eczema in elderly women: effect of air pollution and genes","volume":"143","author":"Huls","year":"2019","journal-title":"J. Allergy. Clin. Immunol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/pai.12903","article-title":"Atopic dermatitis: interaction between genetic variants of GSTP1, TNF, TLR2, and TLR4 and air pollution in early life","volume":"29","author":"Huls","year":"2018","journal-title":"Pediatr. Allergy. Immunol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"801579","DOI":"10.3389\/fimmu.2022.801579","article-title":"Cytokine-mediated crosstalk between keratinocytes and T cells in atopic dermatitis","volume":"7","author":"Humeau","year":"2022","journal-title":"Front. Immunol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.amjms.2018.08.005","article-title":"Development of the pediatric gut microbiome: impact on health and disease","volume":"356","author":"Ihekweazu","year":"2018","journal-title":"Am. J. Med. Sci."},{"key":"B86","doi-asserted-by":"publisher","first-page":"19120","DOI":"10.1038\/s41598-020-76109-y","article-title":"Butyrate induced Tregs are capable of migration from the GALT to the pancreas to restore immunological tolerance during type-1 diabetes","volume":"10","author":"Jacob","year":"2020","journal-title":"Sci. Rep."},{"key":"B87","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1194\/jlr.P030338","article-title":"Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients","volume":"53","author":"Janssens","year":"2012","journal-title":"J. Lipid. Res."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1111\/j.0022-202X.2004.22621.x","article-title":"Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis","volume":"122","author":"Jensen","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1016\/j.jaci.2009.07.015","article-title":"Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis","volume":"124","author":"Jensen","year":"2009","journal-title":"J. Allergy. Clin. Immunol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/sj.bjc.6604890","article-title":"Cancer risk in hospitalised asthma patients","volume":"100","author":"Ji","year":"2009","journal-title":"Br. J. Cancer."},{"key":"B91","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jdermsci.2014.10.001","article-title":"Relationship of ceramide-and free fatty acid-cholesterol ratios in the stratum corneum with skin barrier function of normal, atopic dermatitis lesional and non-lesional skins","volume":"77","author":"Joo","year":"2015","journal-title":"J. Dermatol. Sci."},{"key":"B92","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/cod.12073","article-title":"Eczema and ceramides: an update","volume":"69","author":"Jungersted","year":"2013","journal-title":"Contact. Dermat."},{"key":"B93","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.4049\/jimmunol.1100912","article-title":"Aryl hydrocarbon receptor is critical for homeostasis of invariant gammadelta T cells in the murine epidermis","volume":"187","author":"Kadow","year":"2011","journal-title":"Immunol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/1744666X.2016.1212660","article-title":"Environmental risk factors and their role in the management of atopic dermatitis","volume":"13","author":"Kantor","year":"2017","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.3390\/jcm12041538","article-title":"The role of tight junctions in atopic dermatitis: a systematic review","volume":"12","author":"Katsarou","year":"2023","journal-title":"J. Clin. Med."},{"key":"B96","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.coi.2009.09.006","article-title":"Mast cells in atopic dermatitis","volume":"21","author":"Kawakami","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.jaci.2012.01.068","article-title":"Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice","volume":"129","author":"Kawasaki","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s40265-022-01741-z","article-title":"Nemolizumab: first approval","volume":"82","author":"Keam","year":"2022","journal-title":"Drugs"},{"key":"B99","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.jaci.2019.08.042","article-title":"Treatment of atopic dermatitis with ruxolitinib cream (JAK1\/JAK2 inhibitor) or triamcinolone cream","volume":"145","author":"Kim","year":"2020","journal-title":"J. Allergy. Clin. Immunol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"84","DOI":"10.2500\/aap.2019.40.4202","article-title":"Pathophysiology of atopic dermatitis: clinical implications","volume":"40","author":"Kim","year":"2019","journal-title":"Allergy. Asthma. Proc."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1126\/science.1237013","article-title":"GPR15-mediated homing controls immune homeostasis in the large intestine mucosa","volume":"340","author":"Kim","year":"2013","journal-title":"Science"},{"key":"B102","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s12272-021-01305-x","article-title":"Skin barrier dysfunction and filaggrin","volume":"44","author":"Kim","year":"2021","journal-title":"Arch. Pharm. Res."},{"key":"B103","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/ddg.14668","article-title":"JAK-Inhibitors indermatology-small molecules, big impact? Overview of the mechanism of action, previous study results and potential adverse effects","volume":"20","author":"Klein","year":"2022","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"B104","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.3390\/ijms19103086","article-title":"New cytokines in the pathogenesis of atopic dermatitis-new therapeutic targets","volume":"19","author":"Klonowska","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B105","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.immuni.2015.03.014","article-title":"Dysbiosis and Staphylococcus aureus colonization drives inflammation in atopic dermatitis","volume":"42","author":"Kobayashi","year":"2015","journal-title":"Immunity"},{"key":"B106","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/intimm\/dxz026","article-title":"Host-microbial dialogues in atopic dermatitis","volume":"31","author":"Kobayashi","year":"2019","journal-title":"Int. Immunol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1600-0625.2007.00562.x","article-title":"Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients","volume":"16","author":"Komatsu","year":"2007","journal-title":"Exp. Dermatol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1101\/gr.131029.111","article-title":"Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis","volume":"22","author":"Kong","year":"2012","journal-title":"Genome. Res."},{"key":"B109","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.aller.2013.02.007","article-title":"Relationship between skin prick and atopic patch test reactivity to aeroallergens and disease severity in children with atopic dermatitis","volume":"41","author":"Kutlu","year":"2013","journal-title":"Allergol. Immunopathol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","article-title":"Atopic dermatitis","volume":"396","author":"Langan","year":"2020","journal-title":"Lancet"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.3390\/ijms21041194","article-title":"Molecular mechanism of epidermal barrier dysfunction as primary abnormalities","volume":"21","author":"Lee","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1016\/j.jaad.2018.05.1241","article-title":"A systematic review and meta-analysis of the prevalence and phenotype of adult-onset atopic dermatitis","volume":"80","author":"Lee","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1111\/j.1468-3083.2007.02277.x","article-title":"The effect of wet-wrap dressing on epidermal barrier in patients with atopic dermatitis","volume":"21","author":"Lee","year":"2007","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1146\/annurev.iy.11.040193.000541","article-title":"Defensins: antimicrobial and cytotoxic peptides of mammalian cells","volume":"11","author":"Lehrer","year":"1993","journal-title":"Annu. Rev. Immunol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1067\/mai.2000.106484","article-title":"Atopic dermatitis: new insights and opportunities for therapeutic intervention","volume":"105","author":"Leung","year":"2000","journal-title":"J. Allergy. Clin. Immunol."},{"key":"B116","first-page":"49","article-title":"Atopic dermatitis and the stratum corneum: part 2: other structural and functional characteristics of the stratum corneum barrier in atopic skin","volume":"6","author":"Levin","year":"2013","journal-title":"J. Clin. Aesthet. Dermatol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1080\/14789450.2016.1177462","article-title":"Lipidomic analysis of epidermal lipids: a tool to predict progression of inflammatory skin disease in humans","volume":"13","author":"Li","year":"2016","journal-title":"Expert. Rev. proteomic."},{"key":"B118","doi-asserted-by":"publisher","first-page":"825312","DOI":"10.3389\/fimmu.2022.825312","article-title":"Safety and efficacy of nemolizumab for atopic dermatitis with pruritus: a systematic review and meta-regression analysis of randomized controlled trials","volume":"26","author":"Liang","year":"2022","journal-title":"Front. Immunol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1080\/09546634.2020.1856318","article-title":"Time to meaningful clinical response in reduction of itch in atopic dermatitis","volume":"33","author":"Lin","year":"2022","journal-title":"J. Dermatol. Treat."},{"key":"B120","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jdermsci.2020.10.004","article-title":"Activation of aryl hydrocarbon receptor in Langerhans cells by a microbial metabolite of tryptophan negatively regulates skin inflammation","volume":"100","author":"Liu","year":"2020","journal-title":"J. Dermatol Sci."},{"key":"B121","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/s0738-081x(02)00373-5","article-title":"The skin barrier and use of moisturizers in atopic dermatitis","volume":"21","author":"Loden","year":"2003","journal-title":"Clin. Dermatol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jdermsci.2013.08.003","article-title":"Altered sphingoid base profiles predict compromised membrane structure and permeability in atopic dermatitis","volume":"72","author":"Loiseau","year":"2013","journal-title":"J. Dermatol. Sci."},{"key":"B123","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s40257-020-00549-5","article-title":"Skin microbiome as years go by","volume":"21","author":"Luna","year":"2020","journal-title":"Am. J. Clin. Dermatol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/sj.jid.5701011","article-title":"Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges","volume":"128","author":"Man","year":"2008","journal-title":"J. Investig. Dermatol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1001\/jamadermatol.2020.1948","article-title":"Association between atopic eczema and cancer in england and Denmark","volume":"156","author":"Mansfield","year":"2020","journal-title":"JAMA Dermatol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"2017S","DOI":"10.1093\/jn\/134.8.2017S","article-title":"The stratum corneum barrier: the final frontier","volume":"134","author":"Marks","year":"2004","journal-title":"J. Nutr."},{"key":"B127","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/cea.12406","article-title":"Which infants with eczema are at risk of food allergy? Results from a population-based cohort","volume":"45","author":"Martin","year":"2014","journal-title":"Clin. Exp. Allergy."},{"key":"B128","doi-asserted-by":"publisher","first-page":"100679","DOI":"10.1016\/j.curtheres.2022.100679","article-title":"Safety profile and tolerability of topical phosphodiesterase 4 inhibitors for the treatment of atopic dermatitis: a systematic review and meta-analysis","volume":"23","author":"Mart\u00edn-Santiago","year":"2022","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"B129","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.3390\/nu13092905","article-title":"Human microbiota network: unveiling potential crosstalk between the different microbiota ecosystems and their role in health and disease","volume":"13","author":"Mart\u00ednez","year":"2021","journal-title":"Nutrients"},{"key":"B130","volume-title":"Maruho acquires manufacturing and marketing approval in Japan for \"Mitchga\u00ae Subcutaneous Injection 60mg Syringes\", a new treatment targeting itch associated with atopic dermatitis","year":"2022"},{"key":"B234","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/intimm\/dxv013","article-title":"Dissecting the formation, structure and barrier function of the stratum corneum","author":"Matsui","year":"2015","journal-title":"Int. Immunol."},{"key":"B131","first-page":"925","article-title":"IL-4 and IL-13 inhibition in atopic dermatitis","volume":"15","author":"Matsunaga","year":"2016","journal-title":"J. Drugs. Dermatol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"10954","DOI":"10.1038\/s41598-018-29262-4","article-title":"Cytokine regulation in human CD4 T cells by the aryl hydrocarbon receptor and gq-coupled receptors","volume":"8","author":"McAleer","year":"2018","journal-title":"Sci. Rep."},{"key":"B133","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jaad.2014.01.891","article-title":"The structure, function, and importance of ceramides in skin and their use as therapeutic agents in skin-care products","volume":"71","author":"Meckfessel","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1016\/j.jid.2017.07.834","article-title":"Skin colonization by Staphylococcus aureus precedes the clinical diagnosis of atopic dermatitis in infancy","volume":"137","author":"Meylan","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.4049\/jimmunol.1301228","article-title":"TCF-1 controls ILC2 and NKp46+ROR\u03b3t+ innate lymphocyte differentiation and protection in intestinal inflammation","volume":"191","author":"Mielke","year":"2013","journal-title":"J. Immunol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.jaci.2022.01.028","article-title":"Mechanistic insights into the antipruritic effects of lebrikizumab, an anti-IL-13 mAb","volume":"150","author":"Miron","year":"2022","journal-title":"Allergy. Clin. Immunol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1089\/ars.2012.5149","article-title":"Reactive oxygen species in inflammation and tissue injury","volume":"20","author":"Mittal","year":"2014","journal-title":"Antioxid. Redox. Signal."},{"key":"B138","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jid.2020.05.102","article-title":"Initial evidence of distinguishable bacterial and fungal dysbiosis in the skin of patients with atopic dermatitis or Netherton syndrome","volume":"141","author":"Moosbrugger-Martinz","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"5318","DOI":"10.3390\/ijms23105318","article-title":"Revisiting the roles of filaggrin in atopic dermatitis","volume":"23","author":"Moosbrugger-Martinz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1038\/sj.jid.5700739","article-title":"Filaggrin mutations in children with severe atopic dermatitis","volume":"127","author":"Morar","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3390\/ijms22042025","article-title":"Increased regulatory T cells and decreased myeloid-derived suppressor cells induced by high CCL17 levels may account for normal incidence of cancers among patients with atopic dermatitis","volume":"22","author":"Morimura","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B142","doi-asserted-by":"publisher","first-page":"eaaz8631","DOI":"10.1126\/scitranslmed.aaz8631","article-title":"Therapeutic responses to Roseomonas mucosa in atopic dermatitis may involve lipid-mediated TNF-related epithelial repair","volume":"12","author":"Myles","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"B143","doi-asserted-by":"publisher","first-page":"e120608","DOI":"10.1172\/jci.insight.120608","article-title":"First-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis","volume":"3","author":"Myles","year":"2018","journal-title":"JCI Insight"},{"key":"B144","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fendo.2017.00015","article-title":"Substance P and calcitonin gene-related peptide: key regulators of cutaneous microbiota homeostasis","volume":"30","author":"N'Diaye","year":"2017","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B145","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jaad.2019.12.015","article-title":"Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: a phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study","volume":"82","author":"Nakagawa","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"eaah4680","DOI":"10.1126\/scitranslmed.aah4680","article-title":"Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis","volume":"9","author":"Nakatsuji","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"B147","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1016\/j.jid.2016.05.127","article-title":"Staphylococcus aureus exploits epidermal barrier defects in atopic dermatitis to trigger cytokine expression","volume":"136","author":"Nakatsuji","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41591-021-01256-2","article-title":"Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial","volume":"27","author":"Nakatsuji","year":"2021","journal-title":"Nat. Med."},{"key":"B149","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/jid.2009.384","article-title":"Sebum free fatty acids enhance the innate immune defense of human sebocytes by upregulating \u03b2-defensin-2 expression","volume":"130","author":"Nakatsuji","year":"2010","journal-title":"J. Investig. Dermatol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/bjd.14207","article-title":"The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placebo-controlled study","volume":"174","author":"Nemoto","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"7607","DOI":"10.3390\/ijms21207607","article-title":"Role of antimicrobial peptides in skin barrier repair in individuals with atopic dermatitis","volume":"21","author":"Nguyen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B152","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/exd.13314","article-title":"Friends or foes? Host defense (antimicrobial) peptides and proteins in human skin diseases","volume":"26","author":"Niyonsaba","year":"2017","journal-title":"Exp. Dermatol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/s0022-3476(96)80132-6","article-title":"Topical ointment therapy benefits premature infants","volume":"128","author":"Nopper","year":"1996","journal-title":"J. Pediatr."},{"key":"B154","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/pathogens11010071","article-title":"Host-Microbe interaction on the skin and its role in the pathogenesis and treatment of atopic dermatitis","volume":"11","author":"Nowicka","year":"2022","journal-title":"Pathogens"},{"key":"B155","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1128\/CDLI.6.1.101-104.1999","article-title":"Ceramidase activity in bacterial skin flora as a possible cause of ceramide deficiency in atopic dermatitis","volume":"6","author":"Ohnishi","year":"1999","journal-title":"Clin. Diagn. Lab."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1056\/NEJMoa021481","article-title":"Endog-enous antimicrobial peptides and skin infections in atopic dermatitis","volume":"347","author":"Ong","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"B157","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.2147\/JAA.S342051","article-title":"Management of atopic dermatitis: clinical utility of ruxolitinib","volume":"25","author":"Owji","year":"2022","journal-title":"J. Asthma. Allergy."},{"key":"B158","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/exd.13236","article-title":"Cynomolgus monkey model of interleukin-31-induced scratching depicts blockade of human interleukin-31 receptor A by a humanized monoclonal antibody","volume":"27","author":"Oyama","year":"2018","journal-title":"Exp. Dermatol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0065-2776(09)01203-6","article-title":"Cellular and molecular mechanisms in atopic dermatitis","volume":"102","author":"Oyoshi","year":"2009","journal-title":"Adv. Immunol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3390\/vaccines8030517","article-title":"Immunomodulatory role of the antimicrobial LL-37 peptide in autoimmune diseases and viral infections","volume":"8","author":"Pahar","year":"2020","journal-title":"Vaccines"},{"key":"B161","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jaci.2018.11.015","article-title":"The microbiome in patients with atopic dermatitis","volume":"143","author":"Paller","year":"2019","journal-title":"J. Allergy. Clin. Immunol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jaci.2018.11.006","article-title":"The atopic march and atopic multi-morbidity: many trajectories, many pathways","volume":"143","author":"Paller","year":"2019","journal-title":"J. Allergy. Clin. Immunol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"4232","DOI":"10.3390\/jcm11144232","article-title":"Atopic dermatitis and food allergy: a complex interplay what we know and what we would like to learn","volume":"11","author":"Papapostolou","year":"2022","journal-title":"J. Clin. Med."},{"key":"B164","doi-asserted-by":"publisher","first-page":"e376","DOI":"10.1111\/j.1468-3083.2012.04716.x","article-title":"Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: results from a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison study","volume":"27","author":"Papp","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4161\/derm.1.2.7811","article-title":"Epidermal surface lipids","volume":"1","author":"Pappas","year":"2009","journal-title":"Dermatoendocrinol"},{"key":"B166","doi-asserted-by":"publisher","first-page":"4228","DOI":"10.3390\/ijms22084228","article-title":"Comparative analysis of the microbiome across the gut-skin Axis in atopic dermatitis","volume":"22","author":"Park","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B167","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jid.2020.07.006","article-title":"Which way do we go? Complex interactions in atopic dermatitis pathogenesis","volume":"141","author":"Patrick","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.3390\/ijms23042121","article-title":"Atopic dermatitis: the fate of the fat","volume":"23","author":"Pavel","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B169","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5114\/ada.2018.73159","article-title":"Structure and function of the epidermal barrier in patients with atopic dermatitis-treatment options. Part one","volume":"35","author":"Pelc","year":"2018","journal-title":"Postepy. Dermatol. Alergol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/gut.2006.100164","article-title":"Gut microbiota composition and development of atopic manifestations in infancy: the KOALA birth cohort study","volume":"56","author":"Penders","year":"2007","journal-title":"Gut"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00700","article-title":"Microbiome composition and its impact on the development of allergic diseases","volume":"23","author":"Peroni","year":"2020","journal-title":"Front. Immunol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jmb.2016.12.005","article-title":"Structural characterisation reveals mechanism of IL-13-neutralising monoclonal antibody tralokinumab as inhibition of binding to IL-13r\u03b11 and IL-13r\u03b12","volume":"429","author":"Popovic","year":"2017","journal-title":"J. Mol. Biol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40413-017-0160-5","article-title":"The skin microbiome: impact of modern environments on skin ecology, barrier integrity, and systemic immune programming","volume":"10","author":"Prescott","year":"2017","journal-title":"World. Allergy. Organ. J."},{"key":"B174","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jdermsci.2006.06.003","article-title":"Skin barrier function, epidermal proliferation and differentiation in eczema","volume":"43","author":"Proksch","year":"2006","journal-title":"J. Dermatol. Sci."},{"key":"B175","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.3390\/biomedicines10112700","article-title":"A systematic review of atopic dermatitis: the intriguing journey starting from physiopathology to treatment, from laboratory bench to bedside","volume":"10","author":"Radi","year":"2022","journal-title":"Biomedicines"},{"key":"B176","doi-asserted-by":"publisher","first-page":"126","DOI":"10.5021\/ad.2012.24.2.126","article-title":"Cathelicidin LL37: an anti microbial peptide with a role in inflammatory skin disease","volume":"24","author":"Reinholz","year":"2012","journal-title":"Ann. Dermatol"},{"key":"B177","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jaci.2021.01.001","article-title":"The molecular features of normal and atopic dermatitis skin in infants, children, adolescents, and adults","volume":"148","author":"Renert-Yuval","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"B178","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s40257-021-00647-y","article-title":"The role of diet modification in atopic dermatitis: navigating the complexity","volume":"23","author":"Rustad","year":"2022","journal-title":"Am. J. Clin. Dermatol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.jid.2018.08.035","article-title":"Are environmental factors for atopic eczema in ISAAC Phase Three due to reverse causation?","volume":"139","author":"Rutter","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"B180","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1016\/j.immuni.2021.09.001","article-title":"Disruption of the endopeptidase ADAM10-Notch signaling axis leads to skin dysbiosis and innate lymphoid cell-mediated hair follicle destruction","volume":"54","author":"Sakamoto","year":"2021","journal-title":"Immunity"},{"key":"B181","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/jid.2013.274","article-title":"Warm, humid, and high sun exposure climates are associated with poorly controlled eczema: peer (pediatric eczema elective registry) cohort 2004\u20132012","volume":"134","author":"Sargen","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"B182","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.immuni.2015.10.016","article-title":"A wave of regulatory T cells into neonatal skin MediatesToleranceto commensal microbes","volume":"43","author":"Scharschmidt","year":"2015","journal-title":"Immunity"},{"key":"B183","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1016\/j.jaci.2017.04.010","article-title":"Etiology of epithelial barrier dysfunction in patients with type 2 inflammatory diseases","volume":"139","author":"Schleimer","year":"2017","journal-title":"J. Allergy. Clin. Immunol."},{"key":"B184","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jaci.2009.10.039","article-title":"Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis","volume":"125","author":"Schlievert","year":"2010","journal-title":"J. Allergy. Clin. Immunol."},{"key":"B185","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.0906-6705.2006.00435.x","article-title":"Glucocorticoid therapy-induced skin atrophy","volume":"15","author":"Schoepe","year":"2006","journal-title":"Exp. Dermatol."},{"key":"B186","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.4049\/jimmunol.0901860","article-title":"IL-4 regulates skin homeostasis and the predisposition toward allergic skin inflammation","volume":"184","author":"Sehra","year":"2010","journal-title":"J. Immunol."},{"key":"B187","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/eji.202048887","article-title":"The G protein-coupled receptor 15 (GPR15) regulates cutaneous immunology by maintaining dendritic epidermal T cells and regulating the skin microbiome","volume":"51","author":"Sezin","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/srt.12095","article-title":"Morphological changes in skin of different phototypes under the action of topical corticosteroid therapy and tacrolimus","volume":"20","author":"Shlivko","year":"2014","journal-title":"Skin. Res. Technol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jaad.2014.03.030","article-title":"Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents","volume":"71","author":"Sidbury","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"B190","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1038\/jid.2013.19","article-title":"Climatic factors are associated with childhood eczema prevalence in the United States","volume":"133","author":"Silverberg","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1185\/03007990903512156","article-title":"Atopic dermatitis: a review of topical treatment options","volume":"26","author":"Simpson","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"key":"B192","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1111\/bjd.21867","article-title":"Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials","volume":"9","author":"Simpson","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"e0161877","DOI":"10.1371\/journal.pone.0161877","article-title":"IL-31-Driven skin remodeling involves epidermal cell proliferation and thickening that lead to impaired skin-barrier function","volume":"11","author":"Singh","year":"2016","journal-title":"PloS. One."},{"key":"B194","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1067\/mai.2000.105524","article-title":"Application of Staphylococcal enterotoxin B on normal and atopic skin induces up-regulation of T cells by a superantigen-mediated mechanism","volume":"105","author":"Skov","year":"2000","journal-title":"J. Allergy. Clin. Immunol."},{"key":"B195","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jid.2019.06.142","article-title":"Targeting the cutaneous microbiota in atopic dermatitis by coal tar via AHR-dependent induction of antimicrobial peptides","volume":"140","author":"Smits","year":"2020","journal-title":"J. Invest. Dermatol."},{"key":"B196","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra2023911","article-title":"Atopic dermatitis","volume":"384","author":"St\u00e4nder","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B197","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00105-013-2726-7","article-title":"Basic or maintenance therapy in dermatology. Appropriate vehicles, possibilities and limitations","volume":"65","author":"Staubach","year":"2014","journal-title":"Hautarzt"},{"key":"B198","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1111\/exd.14016","article-title":"Targeting the gut-skin axis-Probiotics as new tools for skin disorder management?","volume":"28","author":"Sz\u00e1nt\u00f3","year":"2019","journal-title":"Exp. Dermatol."},{"key":"B199","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/j.1399-3038.2007.00706.x","article-title":"Emollients improve treatment results with topical corticosteroids in childhood atopic dermatitis: a randomized comparative study","volume":"19","author":"Szczepanowska","year":"2008","journal-title":"Pediatr. Allergy. Immunol."},{"key":"B200","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1111\/jdv.13160","article-title":"Cytokine profiles in interstitial fluid from chronic atopic dermatitis skin","volume":"29","author":"Szegedi","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"B201","doi-asserted-by":"publisher","first-page":"23643","DOI":"10.1073\/pnas.1912432116","article-title":"Keratinocyte-intrinsic MHCII expression controls microbiota-induced Th1 cell responses","volume":"116","author":"Tamoutounour","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B202","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00403-004-0455-6","article-title":"Relative importance of IL-4 and IL-13 in lesional skin of atopic dermatitis","volume":"295","author":"Tazawa","year":"2004","journal-title":"Arch. Dermatol. Res."},{"key":"B203","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jaci.2014.06.014","article-title":"Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis","volume":"134","author":"Thyssen","year":"2014","journal-title":"J. Allergy. Clin. Immunol."},{"key":"B204","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.alit.2021.07.003","article-title":"Subtypes of atopic dermatitis: from phenotype to endotype","volume":"71","author":"Tokura","year":"2022","journal-title":"Allergol. Int."},{"key":"B205","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.3390\/ijms21061958","article-title":"Altered levels of sphingosine, sphinganine and their ceramides in atopic dermatitis are related to skin barrier function, disease severity and local cytokine milieu","volume":"13","author":"Toncic","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B206","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1684\/ejd.2017.2985","article-title":"Expression of keratin 1, keratin 10, desmoglein 1 and desmocollin 1 in the epidermis: possible downregulation by interleukin-4 and interleukin-13 in atopic dermatitis","volume":"27","author":"Totsuka","year":"2017","journal-title":"Eur. J. Dermatol."},{"key":"B207","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/bjd.14566","article-title":"Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis","volume":"175","author":"Tott\u00e9","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"B208","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.jid.2018.12.018","article-title":"Atopic dermatitis is an IL-13\u2013dominant disease with greater molecular heterogeneity compared to psoriasis","volume":"139","author":"Tsoi","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"B209","first-page":"113","article-title":"Atopic eczema and wet-wrap dressings","volume":"14","author":"Twitchen","year":"1998","journal-title":"Prof. Nurse."},{"key":"B210","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.chom.2021.05.011","article-title":"Commensal microbiota regulates skin barrier function and repair via signaling through the aryl hydrocarbon receptor","volume":"29","author":"Uberoi","year":"2021","journal-title":"Cell Host Microbe"},{"key":"B211","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.celrep.2019.09.042","article-title":"Cutaneous immune cell-microbiota interactions are controlled by epidermal JunB\/AP-1","volume":"29","author":"Ulu\u00e7kan","year":"2019","journal-title":"Cell Rep."},{"key":"B212","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jid.2016.09.037","article-title":"An integrated model of atopic dermatitis biomarkers highlights the systemic nature of the disease","volume":"137","author":"Ungar","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"B213","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000441540","article-title":"Stratum corneum lipids: their role for the skin barrier function in healthy subjects and atopic dermatitis patients","volume":"49","author":"van Smeden","year":"2016","journal-title":"Curr. Probl. Dermatol"},{"key":"B214","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.bbalip.2013.11.006","article-title":"The important role of stratum corneum lipids for the cutaneous barrier function","volume":"1841","author":"van Smeden","year":"2014","journal-title":"Biochim. Biophys. Acta."},{"key":"B215","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/exd.12293","article-title":"The importance of free fatty acid chain length for the skin barrier function in atopic eczema patients","volume":"23","author":"van Smeden","year":"2014","journal-title":"Exp. Dermatol."},{"key":"B216","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/bjd\/ljad119","article-title":"Malignancy risk in atopic dermatitis: heterogenous effects and perspectives","volume":"189","author":"Vittrup","year":"2023","journal-title":"Br. J. Dermatol"},{"key":"B217","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s004840000077","article-title":"Influence of weather and climate on subjective symptom intensity in atopic eczema","volume":"45","author":"Vocks","year":"2001","journal-title":"Int. J. Biometeorol."},{"key":"B218","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/bjd\/ljad072","article-title":"Malignancy risk in patients with atopic dermatitis: a population-based cohort study","volume":"189","author":"Wan","year":"2023","journal-title":"Br. J. Dermatol."},{"key":"B219","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1111\/all.13454","article-title":"Birch pollen-related foods can cause late eczematous reactions in patients with atopic dermatitis","volume":"73","author":"Wassmann-Otto","year":"2018","journal-title":"Allergy"},{"key":"B220","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jaci.2015.04.015","article-title":"Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber","volume":"136","author":"Werfel","year":"2015","journal-title":"J. Allergy. Clin. Immunol."},{"key":"B221","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1159\/000491757","article-title":"Epidermal lamellar granules","volume":"31","author":"Wertz","year":"2018","journal-title":"Skin. Pharmacol. Physiol."},{"key":"B222","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1016\/j.celrep.2020.02.021","article-title":"Interplay of staphylococcal and host proteases promotes skin barrier disruption in Netherton syndrome","volume":"30","author":"Williams","year":"2020","journal-title":"Cell. Rep."},{"key":"B223","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000489519","article-title":"Lipids in the skin and pH","volume":"54","author":"Wohlrab","year":"2018","journal-title":"Curr. Probl. Dermatol."},{"key":"B224","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/jdv.14891","article-title":"Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I","volume":"32","author":"Wollenberg","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"B225","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1111\/jdv.16892","article-title":"ETFAD\/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children","volume":"34","author":"Wollenberg","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"B226","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.3390\/ijms23031813","article-title":"The human microbiota and skin cancer","volume":"23","author":"Woo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B227","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jdermsci.2014.11.007","article-title":"Epidermal tight junction barrier function is altered by skin inflammation, but not by filaggrin-deficient stratum corneum","volume":"77","author":"Yokouchi","year":"2015","journal-title":"J. Dermatol. Sci."},{"key":"B228","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jdermsci.2012.11.595","article-title":"Impaired tight junctions obstruct stratum corneum formation by altering polar lipid and profilaggrin processing","volume":"69","author":"Yuki","year":"2013","journal-title":"J. Dermatol. Sci."},{"key":"B229","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1590\/abd1806-4841.20164412","article-title":"Skin barrier in atopic dermatitis: beyond filaggrin","volume":"91","author":"Zaniboni","year":"2016","journal-title":"An. Bras. Dermatol."},{"key":"B230","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1111\/1346-8138.16126","article-title":"Efficacy and safety of topical Janus kinase and phosphodiesterase inhibitor-4 inhibitors for the treatment of atopic dermatitis: a network meta-analysis","volume":"48","author":"Zhang","year":"2021","journal-title":"Dermatol"},{"key":"B231","doi-asserted-by":"publisher","first-page":"R14","DOI":"10.1016\/j.cub.2015.11.017","article-title":"Antimicrobial peptides","volume":"26","author":"Zhang","year":"2016","journal-title":"Curr. Biol."},{"key":"B232","doi-asserted-by":"publisher","first-page":"923362","DOI":"10.3389\/fimmu.2022.923362","article-title":"The efficacy and safety of IL-13 inhibitors in atopic dermatitis: a systematic review and meta-analysis","volume":"27","author":"Zhang","year":"2022","journal-title":"Front. Immunol"},{"key":"B233","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s13555-022-00720-2","article-title":"Atopic dermatitis and skin cancer risk: a systematic review","volume":"12","author":"Zhu","year":"2022","journal-title":"Dermatol. Ther. (Heidelb)."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1159404\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T09:08:55Z","timestamp":1692263335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1159404\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,16]]},"references-count":234,"alternative-id":["10.3389\/fmolb.2023.1159404"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2023.1159404","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,16]]},"article-number":"1159404"}}